Stock unloaded by Robert G Kramer would now be worth only $5.5m while FDA report found unsanitary conditions at plant
The chief executive of the pharmaceutical giant Emergent BioSolutions sold $10m in company stock weeks before the publication of the company’s financial results and a production error that ruined 15m Covid-19 vaccines sent its share price tumbling.
Related: Biden set to announce new mask guidance for vaccinated people – US politics live
